| Female/male (ratio) | Age, median (range) | EDSS, median (range) | Time since diagnosis, median (range) | Patients in clinical relapse, n (%) | Patients with Gd+ lesions on MRI, n (%) | Number of cells/μl CSF, median (range) | IgG index, median (range) |
---|---|---|---|---|---|---|---|---|
Relapsing remitting MS (n = 31) | 20/11 (1.8) | 33 years (20–65) | 1 (0–4.5) | 12 months (0.1–144) | 12 (38.7) | 13 (41.9) | 7 (0.5–45) | 0.81 (0.43–2.2) |